The authors regret that [Fig. 5](#fig0001){ref-type="fig"}, [Fig. 6](#fig0002){ref-type="fig"}, [Fig. 7](#fig0003){ref-type="fig"} were mislabeled in their published article. The correctly labeled figures are provided below.Fig. 5Axial subtraction portal venous phase contrast-enhanced 3D gradient-echo fat-suppressed T1-weighted image demonstrates diffuse enhancement of the pancreatic tail mass with some central heterogeneity (red arrowhead). (Color version of figure is available online.)Fig 5Fig. 6Axial contrast-enhanced CT of the abdomen after chemotherapy shows interval increase in size of previously detected hepatic segment II metastasis (yellow arrowhead), and a new hepatic segment VIII (red arrowhead) metastasis. (Color version of figure is available online.)Fig 6Fig. 7Axial 3D gradient-echo fat-suppressed T1-weighted image without contrast shows near homogeneous intermediate signal intensity of the pancreatic tail mass (red arrowhead). There is no evidence of hemorrhage. (Color version of figure is available online.)Fig 7

The authors would like to apologize for any inconvenience caused.
